Zeo ScientifiX (ZEOX) Non-Current Assets (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Non-Current Assets of $620000.0 for Q2 2026, up 8.77% year-over-year from $570000.0 in Q2 2025, and up 9.93% quarter-over-quarter from $564000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Non-Current Assets (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Non-Current Assets history runs 13 years deep, the most recent figure standing at $620000.0 for Q2 2026.
- In Q2 2026, Non-Current Assets rose 8.77% year-over-year to $620000.0; the TTM figure through Apr 2026 stood at $2.3 million (up 16.87% YoY), while the FY2025 annual figure was $569000.0, up 19.04% from the prior year.
- Non-Current Assets for Q2 2026 stood at $620000.0, up from $564000.0 in the prior quarter.
- The five-year high for Non-Current Assets was $2.2 million in Q3 2022, with the low at $460000.0 in Q1 2025.
- The 5-year median for Non-Current Assets is $584500.0 (2023), against an average of $998095.6.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets surged 196.69% in 2022, then tumbled 68.38% in 2023.
- Zeo ScientifiX's Non-Current Assets stood at $1.8 million in 2022, then sank by 68.38% to $580000.0 in 2023, then fell by 17.59% to $478000.0 in 2024, then rose by 19.04% to $569000.0 in 2025, then rose by 8.96% to $620000.0 in 2026.
- Business Quant data shows ZEOX's Non-Current Assets at $620000.0 in Q2 2026, $564000.0 in Q1 2026, and $569000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 938.60 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 468.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 18.06 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 6.80 Bn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | 620,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 620,000.00 |
| Jan 31, 2026 | 564,000.00 |
| Oct 31, 2025 | 569,000.00 |
| Jul 31, 2025 | 589,000.00 |
| Apr 30, 2025 | 570,000.00 |
| Jan 31, 2025 | 460,000.00 |
| Oct 31, 2024 | 478,000.00 |
| Jul 31, 2024 | 496,000.00 |
| Apr 30, 2024 | 514,000.00 |
| Jan 31, 2024 | 540,000.00 |
| Oct 31, 2023 | 580,000.00 |
| Jul 31, 2023 | 1.38 Mn |
| Apr 30, 2023 | 1.56 Mn |
| Jan 31, 2023 | 1.67 Mn |
| Oct 31, 2022 | 1.83 Mn |
| Jul 31, 2022 | 2.16 Mn |
| Apr 30, 2022 | 1.86 Mn |
| Jan 31, 2022 | 1.53 Mn |
| Oct 31, 2021 | 1.42 Mn |
| Jul 31, 2021 | 882,235.00 |